175 related articles for article (PubMed ID: 25775224)
1. Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.
Campo G; Pavasini R; Malagù M; Punzetti S; Napoli N; Guerzoni F; Papi A; Ceconi C; Contoli M
COPD; 2015; 12(5):560-7. PubMed ID: 25775224
[TBL] [Abstract][Full Text] [Related]
2. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.
Pavasini R; d'Ascenzo F; Campo G; Biscaglia S; Ferri A; Contoli M; Papi A; Ceconi C; Ferrari R
Int J Cardiol; 2015 Jul; 191():187-93. PubMed ID: 25965630
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T.
Søyseth V; Bhatnagar R; Holmedahl NH; Neukamm A; Høiseth AD; Hagve TA; Einvik G; Omland T
Heart; 2013 Jan; 99(2):122-6. PubMed ID: 23024006
[TBL] [Abstract][Full Text] [Related]
5. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital.
Tadros GM; McConnell TR; Wood GC; Costello JM; Iliadis EA
South Med J; 2003 Nov; 96(11):1113-20. PubMed ID: 14632360
[TBL] [Abstract][Full Text] [Related]
9. The influence of heart failure co-morbidity on high-sensitivity troponin T levels in COPD exacerbation in a prospective cohort study: data from the Akershus cardiac examination (ACE) 2 study.
Høiseth AD; Brynildsen J; Hagve TA; Christensen G; Søyseth V; Omland T; Røsjø H
Biomarkers; 2016; 21(2):173-9. PubMed ID: 26754170
[TBL] [Abstract][Full Text] [Related]
10. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
Aviles RJ; Askari AT; Lindahl B; Wallentin L; Jia G; Ohman EM; Mahaffey KW; Newby LK; Califf RM; Simoons ML; Topol EJ; Berger P; Lauer MS
N Engl J Med; 2002 Jun; 346(26):2047-52. PubMed ID: 12087140
[TBL] [Abstract][Full Text] [Related]
11. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
12. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
14. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
16. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
17. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease.
Høiseth AD; Neukamm A; Karlsson BD; Omland T; Brekke PH; Søyseth V
Thorax; 2011 Sep; 66(9):775-81. PubMed ID: 21653926
[TBL] [Abstract][Full Text] [Related]
18. Troponin rise in hospitalized patients with nonacute coronary syndrome: retrospective assessment of outcomes and predictors.
Dhesi S; Shanks M; Tymchak WJ
Can J Cardiol; 2015 Mar; 31(3):296-301. PubMed ID: 25746021
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
